We are live on ! Find out more
NUROW

NeuroMetrix, Inc. Warrants

Delisted

NUROW was delisted on the 26th of May, 2020.

2 hedge funds and large institutions have $1K invested in NeuroMetrix, Inc. Warrants in 2019 Q1 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 2 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 22 (0)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
2
Holders Change
Holders Change %
0%
% of All Funds
0.04%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
2
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$1K -$156 -440 -13%
UBS Group
2
UBS Group
Switzerland
-$27 -75 -4%

NUROW Hedge Fund Activity: Q1 2019 in Review

2 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in NeuroMetrix, Inc. Warrants (NUROW) for Q1 2019, worth a combined $1K.

Fund positioning in NUROW was balanced in Q1 2019: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 2 trimmed.

The largest seller was Susquehanna International Group, cutting an estimated $156.

  • 2 institutional investors held NeuroMetrix, Inc. Warrants (NUROW) as of Q1 2019, unchanged from Q4 2018.
  • Funds reported $1K of NeuroMetrix, Inc. Warrants stock for Q1 2019.
  • 0 funds opened new NeuroMetrix, Inc. Warrants positions in Q1 2019 and 0 closed out.
  • The largest NeuroMetrix, Inc. Warrants seller in Q1 2019 was Susquehanna International Group, an estimated $156 sold.

Based on aggregated 13F filings for Q1 2019.